| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |